These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38453656)
1. Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study. Zhang J; Du Y; Meng Y; Liu X; Mu Y Chin Clin Oncol; 2024 Feb; 13(1):5. PubMed ID: 38453656 [TBL] [Abstract][Full Text] [Related]
2. The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Mhaskar R; Wao H; Miladinovic B; Kumar A; Djulbegovic B Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009624. PubMed ID: 26845108 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey. Cortinovis D; Beretta G; Piazza E; Luchena G; Aglione S; Bertolini A; Buzzoni R; Cabiddu M; Carnaghi C; Danova M; Farina G; Ferrari V; Frascaroli M; Reni M; Tansini G; Tumori; 2013; 99(1):45-50. PubMed ID: 23548999 [TBL] [Abstract][Full Text] [Related]
4. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter. Nordstrom BL; Luo W; Fraeman K; Whyte JL; Nordyke RJ J Manag Care Pharm; 2008; 14(9):858-69. PubMed ID: 19006442 [TBL] [Abstract][Full Text] [Related]
5. Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006. Luo W; Nordstrom BL; Fraeman K; Nordyke R; Ranganathan G; Linz HE; Winterkorn A; Stokes M; Ross SD; Knopf K Clin Ther; 2008 Dec; 30(12):2423-35. PubMed ID: 19167601 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000-2013. Xu L; Xu H; Cannavale K; Sattayapiwat O; Rodriguez R; Page JH; Chao C Support Care Cancer; 2016 Jul; 24(7):2989-98. PubMed ID: 26872791 [TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis-stimulating agents (ESAs): do they still have a role in chemotherapy-induced anemia (CIA)? Bormanis J; Quirt I; Chang J; Kouroukis CT; MacDonald D; Melosky B; Verma S; Couture F Crit Rev Oncol Hematol; 2013 Aug; 87(2):132-9. PubMed ID: 23357249 [TBL] [Abstract][Full Text] [Related]
9. Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea. Kang RY; Lee J; Lee YH; Lee HS; Jeong JH; Lee YJ Int J Clin Pharm; 2012 Aug; 34(4):651-7. PubMed ID: 22729393 [TBL] [Abstract][Full Text] [Related]
10. A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia. Ludwig H; Aapro M; Bokemeyer C; Glaspy J; Hedenus M; Littlewood TJ; Österborg A; Rzychon B; Mitchell D; Beguin Y Support Care Cancer; 2014 Aug; 22(8):2197-206. PubMed ID: 24659244 [TBL] [Abstract][Full Text] [Related]
12. Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey. Ray-Coquard I; Morère JF; Scotté F; Cals L; Antoine EC Adv Ther; 2012 Feb; 29(2):124-33. PubMed ID: 22314432 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia. Boccia RV; Henry DH; Belton L; Bohac C; Ghazal HH Cancer Med; 2016 Dec; 5(12):3445-3453. PubMed ID: 27882724 [TBL] [Abstract][Full Text] [Related]
14. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy. Wauters I; Vansteenkiste J Expert Rev Anticancer Ther; 2012 Nov; 12(11):1383-90. PubMed ID: 23113603 [TBL] [Abstract][Full Text] [Related]
15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chemotherapy-induced anemia]. Kadokura G; Katsumata N Gan To Kagaku Ryoho; 2014 Apr; 41(4):416-20. PubMed ID: 24743356 [TBL] [Abstract][Full Text] [Related]
17. [Questionnaire-based survey on chemotherapy-induced anemia]. Tanaka A Gan To Kagaku Ryoho; 2014 Apr; 41(4):421-5. PubMed ID: 24743357 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced anemia: the story of darbepoetin alfa. Vansteenkiste J; Wauters I; Elliott S; Glaspy J; Hedenus M Curr Med Res Opin; 2013 Apr; 29(4):325-37. PubMed ID: 23323876 [TBL] [Abstract][Full Text] [Related]
19. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. Hoque S; Chen BJ; Schoen MW; Carson KR; Keller J; Witherspoon BJ; Knopf KB; Yang YT; Schooley B; Nabhan C; Sartor O; Yarnold PR; Ray P; Bobolts L; Hrushesky WJ; Dickson M; Bennett CL PLoS One; 2020; 15(6):e0234541. PubMed ID: 32584835 [TBL] [Abstract][Full Text] [Related]